Librela for Dogs: OA Pain Control | VCA Animal Hospitals

Dogs can be so enthusiastic about their favorite activities that they’ll play through
most pain, including pain caused by osteoarthritis.

Your Dog Could Be Dealing With Osteoarthritis Pain

Chronic pain caused by osteoarthritis can interfere with your dog’s daily activities and negatively impact their quality of life. Dogs of all ages, sizes and breeds can have osteoarthritis pain—it’s not just a condition seen in older dogs. If your dog is showing signs of discomfort, schedule an evaluation with your veterinarian.

What Is Osteoarthritis?

Many dogs develop osteoarthritis because of underlying problems, such as developmental joint malformations (like hip or elbow dysplasia), previous injuries or obesity. The severity and pain worsen over time. This gives osteoarthritis a misleading reputation of affecting only seniors, even though the degenerative process typically starts much earlier in life.

White and brown dog on a walk during sunset

Is Librela™ Right for Your Dog?

Librela™ (bedinvetmab) is a monthly injectable treatment administered by your veterinarian that reduces pain associated with canine osteoarthritis (OA), improving your dog’s comfort and quality of life. Each dose is easily administered subcutaneously (under the skin) and is based on your dog’s weight. Librela targets nerve growth factor, a protein which is a key mediator of OA pain. Librela is now available at VCA Animal Hospitals. Discuss treatment options with your veterinarian to determine if Librela is the right solution for your dog.

Your Veterinarian Can Help!

Osteoarthritis pain is manageable. With the return of comfort, dogs can regain mobility and enjoy their regular activities again, improving their overall
quality of life.

Schedule an appointment for an evaluation today.

LIBRELA IMPORTANT SAFETY INFORMATION
See full Librela Prescribing Information. For use in dogs only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. LIBRELA should not be used in breeding, pregnant or lactating dogs. LIBRELA should not be administered to dogs with known hypersensitivity to bedinvetmab. The most common adverse events reported in a clinical study were urinary tract infections, bacterial skin infections and dermatitis.